External Funding Opportunities

Grant Support: The Center Director will happily provide a letter of collaboration to accompany your grant submission. We can also provide biosketches and resources pages, and provide information about standard screening, follow-up and analysis methods, compound collections, instrumentation and Center experience relevant to your goals. We request two week’s notice to prepare customized content for your application.

You may decide that your grant will be more competitive if you can demonstrate that your assay is already optimized for high throughput screening, or present some preliminary results in 384-well format. The Center is happy to work with you to develop such datasets.
 


Upcoming Deadlines


CT Bioscience Innovation Fund

Bioinnovation Connecticut

http://www.bioinnovationct.com/ctbioscience-fund/

Deadlines: Rolling with reviews end of July, October and December


Regeneration Medicine Research Fund

Bioinnovation Connecticut

http://www.bioinnovationct.com/regen/

Deadlines: Rolling with reviews end of July, October and December

Academic Drug Discovery and Development Program

Alzheimer’s Drug Discovery Foundation

http://www.alzdiscovery.org/research-and-grants/request-for-proposal

Deadlines: Letter of intent: 19-May-2017
Invited full proposal: 09-June-2017

National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01)

National Institute of Mental Health/NIH/DHHS

http://grants1.nih.gov/grants/guide/pa-files/PAR-14-184.html

Deadlines: June 2017

Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44)

National Institute of Mental Health/NIH/DHHS

http://grants1.nih.gov/grants/guide/pa-files/PA-14-196.html

Deadlines: June 2017

Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R41/R42)

National Institute of Mental Health/NIH/DHHS

http://grants1.nih.gov/grants/guide/pa-files/PA-14-196.html

Deadlines: 25-May-2017; 25-Sept-2017


Therapeutic Development

High Throughput Screening to Develop Chemical Probes (R03)

Solicitation of Assays for High Throughput Screening (HTS) to Discovery Chemical Probes (R01)


Foundations Supporting Therapeutic Development

Alzheimer’s Drug Discovery Foundation

American Society for Clinical Pharmacology and Therapeutics

Children’s Tumor Foundation

Harrington Institute

Michael J. Fox Foundation for Parkinson’s Research


Program Project Awards (P01)

National Institute on Aging
National Cancer Institute
National Institute for Allergy & Infectious Diseases
National Heart, Lung & Blood Institute
National Institute on Drug Abuse
National Institute of Arthritis & Musculoskeletal & Skin Diseases
National Institute of Neurological Disorders & Stroke
National Institute of Diabetes & Digestive & Kidney Diseases
National Institute of General Medical Sciences
National Institute of Child Health and Human Development
National Institute of Biomedical Imaging and Bioengineering
 


Infectious Diseases

Defense Threat Reduction Agency
DARPA
BARDA
Bill & Melinda Gates Foundation
 


Oncology

American Cancer Society
Cancer Research Institute
CDMRP Breast Cancer Research Program
CDMRP Lung Cancer Research Program
CDMRP Ovarian Cancer Research Program
CDMRP Prostate Cancer Research Program
CDMRP Neurofibromatosis Research Program
Prostate Cancer Foundation
Susan G. Komen Foundation
Damon Runyon Cancer Research Foundation
 


Metabolic Diseases 
Autoimmune Diseases

CDMRP Multiple Sclerosis Research Program
Scleroderma Foundation
 


Cardiovascular Diseases
CNS & Behavioral Diseases

CDMRP ALS Research Program

CDMRP Autism Research Program

CDMRP Gulf War Illness Research Program

CDMRP Traumatic Brain Injury Research Program

Cystic Fibrosis Foundation